Overview

Apremilast - Oral Lichen Planus Trial

Status:
Withdrawn
Trial end date:
2020-04-22
Target enrollment:
Participant gender:
Summary
Apremilast for the management of oral lichen planus.
Phase:
Phase 2
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborators:
Celgene
Sunnybrook Research Institute
Treatments:
Apremilast
Thalidomide